The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma

British Journal of Haematology

Volumn 141, Issue 5, 2008, Pages 615-621

  Zent, Clive S ^a   Ding, Wei ^a   Schwager, Susan M ^a   Reinalda, Megan S ^a   Hoyer, James D ^a   Jelinek, Diane F ^a   Tschumper, Renee C ^a   Bowen, Deborah A ^a   Call, Timothy G ^a   Shanafelt, Tait D ^a   Kay, Neil E ^a   Slager, Susan L ^a  

^a MAYO CLINIC   (United States)

Author keywords

Anaemia; Autoimmune cytopenia; Chronic lymphocytic leukaemia; Prognosis; Thrombocytopenia

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW DEPRESSION; CANCER PATIENT; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; CYTOPENIA; FEMALE; HUMAN; LYMPHOCYTOMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA; AUTOIMMUNE DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; THROMBOCYTOPENIA;

EID: 43449088848     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07086.x     Document Type: Article

References (23)

1. Binet, J.L., Auquier, A., Dighiero, G., Chastang, C., Piguet, H., Goasguen, J., Vaugier, G., Potron, G., Colona, P., Oberling, F., Thomas, M., Tchernia, G., Jacquillat, C., Boivin, P., Lesty, C., Duault, M.T., Monconduit, M., Belabbes, S. Gremy, F. (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer, 48, 198 205.
2. Cheson, B.D., Bennett, J.M., Grever, M., Kay, N., Keating, M.J., O'Brien, S. Rai, K.R. (1996) National Cancer Institute-Sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood, 87, 4990 4997.
3. Crespo, M., Bosch, F., Villamor, N., Bellosillo, B., Colomer, D., Rozman, M., Marce, S., Lopez-Guillermo, S., Campo, E. Montserrat, E. (2003) ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. NewEngland Journal of Medicine, 348, 1764 1775.
4. Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., Lichtman, S.M., Schulman, P., Vinciguerra, V.P., Rai, K.R., Ferrarini, M. Chiorazzi, N. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood, 94, 1840 1847.
5. Dewald, G.W., Brockman, S.R., Paternoster, S.F., Bone, N.D., O'Fallon, J.R., Allmer, C., James, C.D., Jelinek, D.F., Tschumper, R.C., Hanson, C.A., Pruthi, R.K., Witzig, T.E., Call, T.G. Kay, N.E. (2003) Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia. British Journal of Haematology, 121, 287 295.
6. Diehl, L. Ketchum, L. (1998) Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia. Seminars in Oncology, 25, 80 97.
7. Dohner, H., Stilgenbauer, S., Benner, A., Leupolt, E., Kröber, A., Bullinger, L., Döhner, K., Bentz, M. Lichter, P. (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. New England Journal of Medicine, 343, 1910 1916.
8. Gehrs, B. Friedberg, R. (2002) Autoimmune hemolytic anemia. American Journal of Hematology, 69, 258 271.
9. Hamblin, T. (2001) Autoimmune disease and its management in chronic lymphocytic leukemia. In : Chronic Lymphocytic Leukemias (ed. by B. Cheson pp. 435 458. Marcel Dekker, New York, NY.
10. Hamblin, T., Davis, Z., Gardiner, A., Oscier, D. Stevenson, F. (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood, 94, 1848 1854.
11. Harris, N., Jaffe, E., Stein, H., Banks, P., Chan, J., Cleary, M., Delsol, G., De Wolf-Peeters, C., Falini, B. Gatter, K. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 1361 1392.
12. Ibrahim, S., Keating, M., Do, K.A., O'Brien, S., Huh, Y.O., Jilani, I., Lerner, S., Kantarjian, H.M. Albitar, M. (2001) CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood, 98, 181 186.
13. Kay, N.E., Geyer, S.M., Call, T.G., Shanafelt, T.D., Zent, C.S., Jelinek, D.F., Tschumper, R., Bone, N.D., Dewald, G.W., Lin, T.S., Heerema, N.A., Smith, L., Grever, M.R. Byrd, J.C. (2007) Combination chemoimmunotherapy with pentostatin, cyclophosphamide and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B-chronic lymphocytic leukemia. Blood, 109, 405 411.
14. Keating, M.J., O'brien, S., Albitar, M., Lerner, S., Plunkett, W., Giles, F., Andreeff, M., Cortes, J., Faderl, S., Thomas, D., Koller, C., Wierda, W., Detry, M.A., Lynn, A. Kantarjian, H. (2005) Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia. Journal of Clinical Oncology, 23, 4079 4088.
15. Kyasa, M.J., Parrish, R.S., Schichman, S.A. Zent, C.S. (2003) Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma. American Journal of Hematology, 74, 1 8.
16. Kyasa, M.J., Hazlett, L., Parrish, R.S., Schichman, S.A. Zent, C.S. (2004) Veterans with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) have a markedly increased rate of second malignancy, which is the most common cause of death. Leukemia and Lymphoma, 45, 507 513.
17. Mauro, F., Foa, R., Cerretti, R., Giannarelli, D., Coluzzi, S., Mandelli, F. Girelli, G. (2000) Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features. Blood, 95, 2786 2792.
18. Muller-Hermelink, H.K., Catovsky, D., Montserrat, E. Harris, N.L. (2001) Chronic lymphocytic leukemia/small lymphocytic lymphoma. In : Tumours of Haematopoietic and Lymphoid Tissues (ed. by E. Jaffe, N. Harris, H. Stein J. Vardiman pp. 127 130. IARC Press, Lyon.
19. Nowakowski, G.S., Dewald, G.W., Hoyer, J.D., Paternoster, S.F., Stockero, K.J., Fink, S.R., Smoley, S.A., Remstein, E.D., Phyliky, R.L., Call, T.G., Shanafelt, T.D., Kay, N.E. Zent, C.S. (2005) Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia. British Journal of Haematology, 130, 36 42.
20. Rai, K.R., Sawitsky, A., Cronkite, E.P., Chanana, A.D., Levy, R.N. Pasternack, B.S. (1975) Clinical staging of chronic lymphocytic leukemia. Blood, 46, 219 234.
21. Shanafelt, T.D., Witzig, T.E., Fink, S.R., Jenkins, R.B., Paternoster, S.F., Smoley, S.A., Stockero, K.J., Nast, D.M., Flynn, H.C., Tschumper, R.C., Geyer, S., Zent, C.S., Call, T.G., Jelinek, D.F., Kay, N.E. Dewald, G.W. (2006) Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia. Journal of Clinical Oncology, 24, 4634 4641.
22. Zent, C.S., Kyasa, M.J., Evans, R. Schichman, S.A. (2001) Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data. Cancer, 92, 1325 1330.
23. Zent, C.S., Call, T.G., Hogan, W.J., Shanafelt, T.D. Kay, N.E. (2006) Update on risk-stratified management for chronic lymphocytic leukemia. Leukemia and Lymphoma, 47, 1738 1746.